Login / Signup

Effect of Sitagliptin on Serum Irisin Levels in Patients with Newly Diagnosed Type 2 Diabetes Mellitus.

Qiu WangLirong MaYuanying ZhangLin ZhangYu AnJia LiuGuang Wang
Published in: Diabetes therapy : research, treatment and education of diabetes and related disorders (2021)
ClinicalTrials.gov identifier NCT04495881.
Keyphrases
  • newly diagnosed
  • glycemic control
  • cardiovascular risk factors
  • cardiovascular disease
  • adipose tissue